Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ultralife (ULBI) Liabilities and Shareholders Equity (2016 - 2025)

Ultralife (ULBI) has 15 years of Liabilities and Shareholders Equity data on record, last reported at $222.2 million in Q3 2025.

  • For Q3 2025, Liabilities and Shareholders Equity rose 28.88% year-over-year to $222.2 million; the TTM value through Sep 2025 reached $887.4 million, up 26.58%, while the annual FY2024 figure was $220.5 million, 23.66% up from the prior year.
  • Liabilities and Shareholders Equity reached $222.2 million in Q3 2025 per ULBI's latest filing, up from $221.0 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $223.8 million in Q1 2025 and bottomed at $136.4 million in Q1 2021.
  • Average Liabilities and Shareholders Equity over 4 years is $180.1 million, with a median of $175.8 million recorded in 2023.
  • Peak YoY movement for Liabilities and Shareholders Equity: decreased 6.68% in 2021, then skyrocketed 30.12% in 2025.
  • A 4-year view of Liabilities and Shareholders Equity shows it stood at $136.8 million in 2021, then soared by 30.31% to $178.3 million in 2023, then rose by 23.66% to $220.5 million in 2024, then grew by 0.81% to $222.2 million in 2025.
  • Per Business Quant database, its latest 3 readings for Liabilities and Shareholders Equity were $222.2 million in Q3 2025, $221.0 million in Q2 2025, and $223.8 million in Q1 2025.